188 related articles for article (PubMed ID: 32920368)
1. Cell motility and migration as determinants of stem cell efficacy.
Danielyan L; Schwab M; Siegel G; Brawek B; Garaschuk O; Asavapanumas N; Buadze M; Lourhmati A; Wendel HP; Avci-Adali M; Krueger MA; Calaminus C; Naumann U; Winter S; Schaeffeler E; Spogis A; Beer-Hammer S; Neher JJ; Spohn G; Kretschmer A; Krämer-Albers EM; Barth K; Lee HJ; Kim SU; Frey WH; Claussen CD; Hermann DM; Doeppner TR; Seifried E; Gleiter CH; Northoff H; Schäfer R
EBioMedicine; 2020 Oct; 60():102989. PubMed ID: 32920368
[TBL] [Abstract][Full Text] [Related]
2. Modulating endothelial adhesion and migration impacts stem cell therapies efficacy.
Schäfer R; Schwab M; Siegel G; von Ameln-Mayerhofer A; Buadze M; Lourhmati A; Wendel HP; Kluba T; Krueger MA; Calaminus C; Scheer E; Dominici M; Grisendi G; Doeppner TR; Schlechter J; Finzel AK; Gross D; Klaffschenkel R; Gehring FK; Spohn G; Kretschmer A; Bieback K; Krämer-Albers EM; Barth K; Eckert A; Elser S; Schmehl J; Claussen CD; Seifried E; Hermann DM; Northoff H; Danielyan L
EBioMedicine; 2020 Oct; 60():102987. PubMed ID: 32942121
[TBL] [Abstract][Full Text] [Related]
3. A preclinical evaluation of neural stem cell-based cell carrier for targeted antiglioma oncolytic virotherapy.
Ahmed AU; Thaci B; Tobias AL; Auffinger B; Zhang L; Cheng Y; Kim CK; Yunis C; Han Y; Alexiades NG; Fan X; Aboody KS; Lesniak MS
J Natl Cancer Inst; 2013 Jul; 105(13):968-77. PubMed ID: 23821758
[TBL] [Abstract][Full Text] [Related]
4. HuCNS-SC Human NSCs Fail to Differentiate, Form Ectopic Clusters, and Provide No Cognitive Benefits in a Transgenic Model of Alzheimer's Disease.
Marsh SE; Yeung ST; Torres M; Lau L; Davis JL; Monuki ES; Poon WW; Blurton-Jones M
Stem Cell Reports; 2017 Feb; 8(2):235-248. PubMed ID: 28199828
[TBL] [Abstract][Full Text] [Related]
5. A comparative study of neural and mesenchymal stem cell-based carriers for oncolytic adenovirus in a model of malignant glioma.
Ahmed AU; Tyler MA; Thaci B; Alexiades NG; Han Y; Ulasov IV; Lesniak MS
Mol Pharm; 2011 Oct; 8(5):1559-72. PubMed ID: 21718006
[TBL] [Abstract][Full Text] [Related]
6. Human neural stem cells improve cognition and promote synaptic growth in two complementary transgenic models of Alzheimer's disease and neuronal loss.
Ager RR; Davis JL; Agazaryan A; Benavente F; Poon WW; LaFerla FM; Blurton-Jones M
Hippocampus; 2015 Jul; 25(7):813-26. PubMed ID: 25530343
[TBL] [Abstract][Full Text] [Related]
7. Neural stem cell-based cell carriers enhance therapeutic efficacy of an oncolytic adenovirus in an orthotopic mouse model of human glioblastoma.
Ahmed AU; Thaci B; Alexiades NG; Han Y; Qian S; Liu F; Balyasnikova IV; Ulasov IY; Aboody KS; Lesniak MS
Mol Ther; 2011 Sep; 19(9):1714-26. PubMed ID: 21629227
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of FOXQ1 enhances anti-senescence and migration effects of human umbilical cord mesenchymal stem cells in vitro and in vivo.
Zhang T; Wang P; Liu Y; Zhou J; Shi Z; Cheng K; Huang T; Wang X; Yang GL; Yang B; Ma S; Guan F
Cell Tissue Res; 2018 Aug; 373(2):379-393. PubMed ID: 29500491
[TBL] [Abstract][Full Text] [Related]
9. Preconditioning mesenchymal stem cells with the mood stabilizers lithium and valproic acid enhances therapeutic efficacy in a mouse model of Huntington's disease.
Linares GR; Chiu CT; Scheuing L; Leng Y; Liao HM; Maric D; Chuang DM
Exp Neurol; 2016 Jul; 281():81-92. PubMed ID: 27085395
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic modulation of nasal epithelium augments neural stem cell targeting of glioblastoma.
Spencer D; Yu D; Morshed RA; Li G; Pituch KC; Gao DX; Bertolino N; Procissi D; Lesniak MS; Balyasnikova IV
Theranostics; 2019; 9(7):2071-2083. PubMed ID: 31037157
[TBL] [Abstract][Full Text] [Related]
11. Targeted intra-arterial transplantation of stem cells to the injured CNS is more effective than intravenous administration: engraftment is dependent on cell type and adhesion molecule expression.
Lundberg J; Södersten E; Sundström E; Le Blanc K; Andersson T; Hermanson O; Holmin S
Cell Transplant; 2012; 21(1):333-43. PubMed ID: 21669035
[TBL] [Abstract][Full Text] [Related]
12. Feasibility and Efficacy of Intra-Arterial Administration of Embryonic Stem Cell Derived-Mesenchymal Stem Cells in Animal Model of Alzheimer's Disease.
Kim DY; Choi SH; Lee JS; Kim HJ; Kim HN; Lee JE; Shin JY; Lee PH
J Alzheimers Dis; 2020; 76(4):1281-1296. PubMed ID: 32597802
[TBL] [Abstract][Full Text] [Related]
13. Intranasal delivery of bone marrow-derived mesenchymal stem cells, macrophages, and microglia to the brain in mouse models of Alzheimer's and Parkinson's disease.
Danielyan L; Beer-Hammer S; Stolzing A; Schäfer R; Siegel G; Fabian C; Kahle P; Biedermann T; Lourhmati A; Buadze M; Novakovic A; Proksch B; Gleiter CH; Frey WH; Schwab M
Cell Transplant; 2014; 23 Suppl 1():S123-39. PubMed ID: 25302802
[TBL] [Abstract][Full Text] [Related]
14. Gene Therapy Using Neural Stem/Progenitor Cells Derived from Human Induced Pluripotent Stem Cells: Visualization of Migration and Bystander Killing Effect.
Tamura R; Miyoshi H; Morimoto Y; Oishi Y; Sampetrean O; Iwasawa C; Mine Y; Saya H; Yoshida K; Okano H; Toda M
Hum Gene Ther; 2020 Mar; 31(5-6):352-366. PubMed ID: 32075424
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol promotes hUC-MSCs engraftment and neural repair in a mouse model of Alzheimer's disease.
Wang X; Ma S; Yang B; Huang T; Meng N; Xu L; Xing Q; Zhang Y; Zhang K; Li Q; Zhang T; Wu J; Yang GL; Guan F; Wang J
Behav Brain Res; 2018 Feb; 339():297-304. PubMed ID: 29102593
[TBL] [Abstract][Full Text] [Related]
16. Intranasal delivery of neural stem/progenitor cells: a noninvasive passage to target intracerebral glioma.
Reitz M; Demestre M; Sedlacik J; Meissner H; Fiehler J; Kim SU; Westphal M; Schmidt NO
Stem Cells Transl Med; 2012 Dec; 1(12):866-73. PubMed ID: 23283548
[TBL] [Abstract][Full Text] [Related]
17. Exploring the Potential of Mesenchymal Stem Cell-Based Therapy in Mouse Models of Vascular Cognitive Impairment.
Lee NK; Kim H; Chang JW; Jang H; Kim H; Yang J; Kim J; Son JP; Na DL
Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32752272
[TBL] [Abstract][Full Text] [Related]
18. Intranasal delivery of mesenchymal stem cells significantly extends survival of irradiated mice with experimental brain tumors.
Balyasnikova IV; Prasol MS; Ferguson SD; Han Y; Ahmed AU; Gutova M; Tobias AL; Mustafi D; Rincón E; Zhang L; Aboody KS; Lesniak MS
Mol Ther; 2014 Jan; 22(1):140-8. PubMed ID: 24002694
[TBL] [Abstract][Full Text] [Related]
19. Tissue-derived mesenchymal stromal cells used as vehicles for anti-tumor therapy exert different in vivo effects on migration capacity and tumor growth.
Belmar-Lopez C; Mendoza G; Oberg D; Burnet J; Simon C; Cervello I; Iglesias M; Ramirez JC; Lopez-Larrubia P; Quintanilla M; Martin-Duque P
BMC Med; 2013 May; 11():139. PubMed ID: 23710709
[TBL] [Abstract][Full Text] [Related]
20. Human Neural Stem Cell Biodistribution and Predicted Tumor Coverage by a Diffusible Therapeutic in a Mouse Glioma Model.
Barish ME; Herrmann K; Tang Y; Argalian Herculian S; Metz M; Aramburo S; Tirughana R; Gutova M; Annala A; Moats RA; Goldstein L; Rockne RC; Gutierrez J; Brown CE; Ghoda L; Aboody KS
Stem Cells Transl Med; 2017 Jun; 6(6):1522-1532. PubMed ID: 28481046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
